Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.InSite Vision names new interim CEO
Mr Drapeau will lead the day-to-day operations of the company while retaining his current CFO responsibilities. An active CEO search has been initiated. In addition, Evan Melrose has
Mr Drapeau will lead the day-to-day operations of the company while retaining his current CFO responsibilities. An active CEO search has been initiated. In addition, Evan Melrose has
Dr Berendt is currently a director of Waters Corporation and has served on the board of directors of numerous other life sciences companies. Dr Berendt has received a
Also, Alastair McEwan, chairman of the board of Cornerstone BioPharma, has been appointed to the board of directors of Cornerstone Therapeutics. Concurrently, Cornerstone Therapeutics also appointed three independent
Michael Boswell has been appointed to the board and will assume Mr MacLellan’s former role as chairman of AMDL’s audit committee and board member William Thompson will assume
Pursuant to the terms of the amicable agreement, Vyta now controls 100% ownership interest in Bioagra and Paul Metzinger, president and CEO of Vyta becomes the sole manager,
Impulse Monitoring (IMI) will provide St Vincent’s with comprehensive intraoperative neuromonitoring (IONM) services including IMI-qualified neurophysiologists and real-time professional oversight experienced physicians. IONM assesses neurological function involving the
Advinus will combine its services with AgilityBio’s imaging services that use BioImagene’s digital pathology solutions for cancer diagnosis and research. This partnership will bring about a synergy between
The agreement provides Eclipse Medical with the rights to sell in the Netherlands, and includes minimum purchase requirements. The SonaStar is used by neuro and general surgeons for
The first tier of Signature’s prenatal service, the enhanced PrenatalChip targets over 100 discrete chromosomal regions, the gain or loss of which results in a genetic disorder, while
In recent years, the US hospital market has received this product through an exclusive distribution arrangement with Abbott. OraSure and Abbott have previously entered into an agreement under